ECSP972183A - AVIARY POLYNUCLEOTIDIC VACCINE FORMULA - Google Patents

AVIARY POLYNUCLEOTIDIC VACCINE FORMULA

Info

Publication number
ECSP972183A
ECSP972183A ECSP972183A ECSP972183A EC SP972183 A ECSP972183 A EC SP972183A EC SP972183 A ECSP972183 A EC SP972183A EC SP972183 A ECSP972183 A EC SP972183A
Authority
EC
Ecuador
Prior art keywords
virus
disease virus
polynucleotidic
aviary
vaccine formula
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jean Christophe Francis Audonnet
Michel Riviere
Annabelle Bouchardon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972183 priority Critical patent/ECSP972183A/en
Publication of ECSP972183A publication Critical patent/ECSP972183A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La fórmula de vacuna aviaria comprende al menos 3 valencias de vacuna polinucleotídica, cada una de las cuales comprende un plásmido integrante de manera de expresar in vivo en las células huesped un gen de una valencia de patagonia aviaria, estado eligido estas valencias del grupo que comprende virus de la enfermedad de Marek, virus de la enfermedad de Newvstie, virus de la enfermedad de Gumboro, virus de la bronquitis infecciosa, virus de la anemia infecciosa, comprendiendo los plásmidos para cada valencia uno o varios de los genes elegidos del grupo que comprende gB y gD para el virus de la enfermedad de Marek, HN y F para el virus de la enfermedad de Newcastle, VP2 para el virus de la enfermedad de Gumboro, S M y N para el virus de la bronquitis infecciosa, C+NS1 para el virus de la anemia infecciosa.The avian vaccine formula comprises at least 3 valencies of polynucleotide vaccine, each of which comprises an integrating plasmid in order to express in vivo in the host cells a gene of a valency of avian patagonia, these valences being chosen from the group comprising Marek's disease virus, Newvstie's disease virus, Gumboro disease virus, infectious bronchitis virus, infectious anemia virus, the plasmids for each valence comprising one or more of the genes chosen from the group comprising gB and gD for the Marek's disease virus, HN and F for the Newcastle disease virus, VP2 for the Gumboro disease virus, SM and N for the infectious bronchitis virus, C + NS1 for the infectious anemia virus.

ECSP972183 1997-07-15 1997-07-15 AVIARY POLYNUCLEOTIDIC VACCINE FORMULA ECSP972183A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972183 ECSP972183A (en) 1997-07-15 1997-07-15 AVIARY POLYNUCLEOTIDIC VACCINE FORMULA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972183 ECSP972183A (en) 1997-07-15 1997-07-15 AVIARY POLYNUCLEOTIDIC VACCINE FORMULA

Publications (1)

Publication Number Publication Date
ECSP972183A true ECSP972183A (en) 1998-11-23

Family

ID=42043014

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972183 ECSP972183A (en) 1997-07-15 1997-07-15 AVIARY POLYNUCLEOTIDIC VACCINE FORMULA

Country Status (1)

Country Link
EC (1) ECSP972183A (en)

Similar Documents

Publication Publication Date Title
CO4700304A1 (en) AVIARY POLYNUCLEOTIDIC VACCINE FORMULA
AR007861A1 (en) FORMULA OF VACCINE FOR CATS, ITS USE AND VACCINATION KIT
Singh et al. Re-emerging fowlpox: evaluation of isolates from vaccinated flocks
CO4700306A1 (en) PARTICULARLY PLINUCLEOTICAL VACCINE FORMULA AGAINST RESPIRATORY PATHOLOGY OF CATTLE
AR059828A2 (en) VACCINE FORMULA FOR EQUIPMENT, ITS USE AND VACCINATION KIT
García et al. Commercial vaccines and vaccination strategies against infectious laryngotracheitis: what we have learned and knowledge gaps that remain
PE52599A1 (en) LIVING AVIARY RECOMBINANT VACCINE, WHICH INCLUDES AS VECTOR THE INFECTIOUS LARYNGROCHEITIS VIRUS
Perozo et al. Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain
ES2524359T3 (en) Porcine circovirus, nucleic acids, polypeptides and vaccines
Singh et al. Reticuloendotheliosis virus sequences within the genomes of field strains of fowlpox virus display variability
RU2019136150A (en) VACCINES AGAINST RECOMBINANT HERPESVIRUS GALLID 3, CODING HETEROLOGICAL ANTIGENS OF THE AVIAN PATHOGEN
AR010102A1 (en) A LIVING RECOMBINANT VACCINE AVIARY THAT UNDERSTANDS AS A VECTOR AN ILTV VIRUS THAT UNDERSTANDS AND EXPRESSES AT LEAST ONE NUCLEOTIDIC SEQUENCE
ES2143507T3 (en) VACCINES AGAINST AUJESZKY DISEASE AND OTHER ANIMAL DISEASES CONTAINING MUTANTS OF PSEUDORRABIA VIRUSES.
CA2283093A1 (en) Recombinant chimeric viruses and uses thereof
MX9101042A (en) RECOMBINANT DNA AND RNA AND PRODUCTS DERIVED FROM THEM
RU2019102170A (en) DUCK ENTERITIS VIRUS AND ITS APPLICATION
Ottiger Development, standardization and assessment of PCR systems for purity testing of avian viral vaccines
ECSP972183A (en) AVIARY POLYNUCLEOTIDIC VACCINE FORMULA
Han et al. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction–restriction fragment length polymorphism
Smith et al. Comparison of an avian osteopetrosis virus with an avian lymphomatosis virus by RNA-DNA hybridization
DK0510996T3 (en) Recombinant varicella-zoster virus vector
CA2478081A1 (en) Multiple and multivalent dna vaccines in ovo
Hirai et al. Polyvalent recombinant Marek’s disease virus vaccine against poultry diseases
Sheppard Viral vectors for veterinary vaccines
Kibenge et al. Identification of serotype II infectious bursal disease virus proteins